Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 10, 2019
Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants
Shin-Ichiro Hattori, Hironori Hayashi, Haydar Bulut, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
David A Davis, Haydar Bulut, Prabha Shrestha, et al.
Mbio
|
August 17, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
David A Davis, Haydar Bulut, Prabha Shrestha, et al.
ACS Omega
|
February 2, 2026
Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease
Haydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2016
A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413
Masayuki Amano, Pedro Miguel Salcedo-Gómez, Rui Zhao, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2019
Novel Protease Inhibitors Containing C-5-Modified <i>bis</i>-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance
Yuki Takamatsu, Manabu Aoki, Haydar Bulut, et al.
Journal of Medicinal Chemistry
|
September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Scientific Reports
|
July 2, 2020
Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
Haydar Bulut, Shin-Ichiro Hattori, Hiromi Aoki-Ogata, et al.
Chemical & Pharmaceutical Bulletin
|
December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement
Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
RSC Advances
|
June 2, 2023
Synthesis of novel entecavir analogues having 4'-cyano-6''-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent
Hiroki Kumamoto, Nobuyo Higashi-Kuwata, Sanae Hayashi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Antimicrobial Agents and Chemotherapy
|
April 10, 2019
Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants
Shin-Ichiro Hattori, Hironori Hayashi, Haydar Bulut, et al.
Biorxiv : the Preprint Server for Biology
|
April 14, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
David A Davis, Haydar Bulut, Prabha Shrestha, et al.
Mbio
|
August 17, 2021
Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300
David A Davis, Haydar Bulut, Prabha Shrestha, et al.
ACS Omega
|
February 2, 2026
Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease
Haydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2016
A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413
Masayuki Amano, Pedro Miguel Salcedo-Gómez, Rui Zhao, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2019
Novel Protease Inhibitors Containing C-5-Modified <i>bis</i>-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance
Yuki Takamatsu, Manabu Aoki, Haydar Bulut, et al.
Journal of Medicinal Chemistry
|
September 27, 2023
Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.
Scientific Reports
|
July 2, 2020
Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
Haydar Bulut, Shin-Ichiro Hattori, Hiromi Aoki-Ogata, et al.
Chemical & Pharmaceutical Bulletin
|
December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement
Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.
RSC Advances
|
June 2, 2023
Synthesis of novel entecavir analogues having 4'-cyano-6''-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent
Hiroki Kumamoto, Nobuyo Higashi-Kuwata, Sanae Hayashi, et al.
Page
of 4